InspireMD Inc.
NSPR | NASDAQ
$0.76
+$0.01 (+1.33%)
Sep 22, 2026, 12:17 PM ET · Market open
Company Profile
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
Key Executives
| Name | Position |
|---|---|
| Marvin L. Slosman | President, Chief Executive Officer & Director |
| Amir Kohen | Executive Vice President of Finance & Regional Manager |
| Donna DeChant | Vice President of Human Resources & Organizational Development |
| Kathleen Kennedy | Senior Vice President of Global Sales & Marketing |
| Michael A. Lawless | CFO, Secretary & Treasurer |
| Pete Ligotti | Executive Vice President & GM of North America |
| Peter A. Soukas | Chief Medical Officer |
| Shane Thomas Gleason | Chief Commercial Officer |
| Sol J. Barer | Special Advisor to the Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 17, 2026 | 8-K | Current Report |
| Aug 14, 2026 | 10-Q | Quarterly Report |
| Jul 29, 2026 | 8-K | Current Report |
| Jul 23, 2026 | 8-K | Current Report |
| Jul 02, 2026 | 8-K | Current Report |
| Jun 11, 2026 | 8-K | Current Report |
| May 29, 2026 | 4 | Filing |
| May 22, 2026 | 8-K | Current Report |
| May 21, 2026 | 4 | Filing |
| May 15, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
InspireMD Inc.
| Country | United States |
| IPO Date | Apr 11, 2011 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 127 |
| CEO | Marvin L. Slosman |
Contact Details
6303 Waterford District Drive Miami,
Florida 33126 United States
Stock Details
| Ticker Symbol | NSPR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001433607 |
| CUSIP Number | 45779A846 |
| ISIN Number | US45779A8466 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove NSPR